IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 42
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2007 Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs Ang, Wh; De Luca, A; Chapuis-Bernasconi, C; Juillerat-Jeanneret, L; Lo Bello, M; Dyson, Pj Articolo su rivista
1-gen-2009 IMPORTANCE OF THE ANTIOXIDANT AND DETOXIFICANT GLUTATHIONE TRANSFERASE P1-1 IN CIRCUMVENTING THE ACQUIRED DRUG RESISTANCE IN BREST CANCER CELLS. LO BELLO, M; De Luca, A; Moroni, N; Serafino, A; Pastore, A; Pedersen, Jz; Petruzzelli, ; Farrace, Mg; Pierimarchi, P; Moroni, G; Federici, G; SINIBALDI VALLEBONA, P Intervento a convegno
1-gen-2009 Monomer-Dimer Equilibrium in Glutathione Transferases: A Critical Re-Examination De Luca, A; Fabrini, R; Orioni, B; Stella, L; Mei, G; Federici, G; Ricci, G; Lo Bello, M Articolo su rivista
1-gen-2009 Rational design of an organometallic glutathione transferase inhibitor Ang, W; Parker, L; De Luca, A; Juillerat-Jeanneret, L; Morton, C; Lo Bello, M; Parker, M; Dyson, P Articolo su rivista
1-gen-2010 Allergic contact dermatitis: novel mechanisms and therapeutic perspectives Cavani, A; De Luca, A Articolo su rivista
1-gen-2011 Treatment of doxorubicin resistant MCF7/Dx cells with nitric oxide causes histone glutathionylation and reversal of drug resistance. De Luca, A; Moroni, N; Serafino, A; Primavera, A; Pastore, A; Pedersen, Jz; Petruzzelli, R; Farrace, Mg; Pierimarchi, P; Moroni, G; Federici, G; SINIBALDI VALLEBONA, P; LO BELLO, M Articolo su rivista
4-lug-2011 Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activation Parker, L; Italiano, L; Morton, C; Hancock, N; Ascher, D; Aitken, J; Harris, H; Campomanes, P; Rothlisberger, U; De Luca, A; LO BELLO, M; Ang, W; Dyson, P; Parker, M Articolo su rivista
1-gen-2012 New Insights into the Mechanism of JNK1 Inhibition by Glutathione Transferase P1-1 De Luca, A; Federici, L; De Canio, M; Stella, L; Caccuri, Am Articolo su rivista
1-feb-2013 Glutathione S-transferase P1-1 as a target for mesothelioma treatment De Luca, A; Pellizzari Tregno, F; Sau, A; Pastore, A; Palumbo, C; Alama, A; Cicconi, R; Federici, G; Caccuri, Am Articolo su rivista
1-feb-2013 A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin De Luca, A; Hartinger, C; Dyson, P; LO BELLO, M; Casini, A Articolo su rivista
1-gen-2014 The fine-tuning of TRAF2-GSTP1-1 interaction: effect of ligand binding and in situ detection of the complex De Luca, A; Mei, G; Rosato, N; Nicolai, E; Federici, L; Palumbo, C; Pastore, A; Serra, M; Caccuri, Am Articolo su rivista
1-gen-2015 A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells DE LUCA, A; Graziani, G; Rotili, D; Muzi, A; Mai, A; Leonetti, C; Artuso, S; Bonanno, E; Tentori, L; Caccuri, Am Intervento a convegno
1-gen-2015 Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients Avitabile, S; Sordi, D; Garcovich, S; Colonna, L; De Luca, A; Nasorri, F; Mazzanti, C; Cavani, A Articolo su rivista
1-gen-2015 Synthesis and structure-activity relationship of new cytotoxic agents targeting human glutathione-S-transferases Rotili, D; De Luca, A; Tarantino, D; Pezzola, S; Forgione, M; Della Rocca, B; Falconi, M; Mai, A; Caccuri, A Articolo su rivista
1-gen-2015 A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts De Luca, A; Rotili, D; Carpanese, D; Lenoci, A; Calderan, L; Scimeca, M; Mai, A; Bonanno, E; Rosato, A; Geroni, C; Quintieri, L; Caccuri, Am; DE LUCA, A Articolo su rivista
1-gen-2015 A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib Graziani, G; Artuso, S; De Luca, A; Muzi, A; Rotili, D; Scimeca, M; Atzori, M; Ceci, C; Mai, A; Leonetti, C; Levati, L; Bonanno, E; Tentori, L; Caccuri, Am Articolo su rivista
1-gen-2015 TNFR-Associated Factor-2 (TRAF2): Not only a Trimer Ceccarelli, A; DI VENERE, A; Nicolai, E; DE LUCA, A; Minicozzi, V; Rosato, N; Caccuri, Am; Mei, G Articolo su rivista
23-giu-2015 Nitrobenzoxadiazoles exert anti-melanoma activity modulating the MAPK/JNK signalling De Luca, A; Rotili, D; Carpanese, D; Mai, A; Rosato, A; Graziani, G; Leonetti, C; Geroni, C; Quintieri, L; Caccuri, A Intervento a convegno
1-gen-2016 Nitrobenzoxadiazole-based GSTP1-1 inhibitors containing the full peptidyl moiety of (pseudo)glutathione Luisi, G; Mollica, A; Carradori, S; Lenoci, A; De Luca, A; Caccuri, Am Articolo su rivista
4-feb-2016 c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition Palumbo, C; De Luca, A; Rosato, N; Forgione, M; Rotili, D; Caccuri, Am Articolo su rivista
Mostrati risultati da 1 a 20 di 42
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile